4//SEC Filing
Boxer Gene 4
Accession 0001140361-21-007038
CIK 0001744894other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:38 PM ET
Size
6.8 KB
Accession
0001140361-21-007038
Insider Transaction Report
Form 4
Boxer Gene
EVP, CSO & Group Gen. Counsel
Transactions
- Disposition to Issuer
Common Shares
2021-02-26−8,049→ 97,646 total - Disposition to Issuer
Common Shares
2021-02-26−97,646→ 0 total
Footnotes (2)
- [F1]Represents shares of common stock of the issuer ("Sirius Shares") disposed of in connection with the merger of the issuer with Third Point Reinsurance Ltd. ("TPRE") (the "Merger"), which closed on February 26, 2021 (the "Effective Time"), and exchanged for a combination of common shares, par value $0.10 per share, of TPRE (the "TPRE Shares") and contingent value right ("CVR") consideration comprising (1) 0.743 of a TPRE Share and (2) one contractual CVR, which represents the right to receive a contingent cash payment, which, taken together with the fraction of the TPRE Share received, guarantee that on the second anniversary of the Effective Time, the electing shareholder will have received equity and cash equal to at least $13.73 per Sirius Share.
- [F2]Represents restricted stock units ("RSUs") scheduled to vest in full on the third anniversary of grant date (or on February 27, 2022). These RSUs were disposed of in connection with the Merger and exchanged for 126,685 RSUs of TPRE common shares that immediately vested following the closing of the Merger and will be settled, net of shares withheld for taxes, for cash at the public trading price on the day of the cash-out.
Documents
Issuer
Sirius International Insurance Group, Ltd.
CIK 0001744894
Entity typeother
Related Parties
1- filerCIK 0001758152
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:38 PM ET
- Size
- 6.8 KB